# VERAPAMIL HCI

NDC: 51662-1442
Generic name: VERAPAMIL HCI
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20191222

FDA application: NDA018925

## Active ingredients

- VERAPAMIL HYDROCHLORIDE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1442"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1442
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a4f12ec-fe1c-a1b9-e053-2a95a90ac8e4